Higher NK cell IFN-γ production is associated with delayed HIV disease progression in LTNPs

Journal of Clinical Immunology

Volumn 33, Issue 8, 2013, Pages 1376-1385

  Jiang, Yongjun ^a   Zhou, Fangyuan ^a   Tian, Yao ^a   Zhang, Zining ^a   Kuang, Rongmei ^a   Liu, Jing ^a   Han, Xiaoxu ^a   Hu, Qinghai ^a   Xu, Junjie ^a   Shang, Hong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CD107a; HIV; IFN ; LTNP; NK cell

Indexed keywords

GAMMA INTERFERON; GRANZYME B; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MIDDLE AGED; NATURAL KILLER CELL; PRIMARY INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; VIRUS LOAD; YOUNG ADULT;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DISEASE PROGRESSION; DOWN-REGULATION; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; K562 CELLS; KILLER CELLS, NATURAL; MIDDLE AGED; TIME FACTORS; UP-REGULATION; VIRAL LOAD; YOUNG ADULT;

EID: 84889102045     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-013-9930-1     Document Type: Article

References (34)

1. Alter G, Altfeld M. NK cell function in HIV-1 infection. Curr Mol Med. 2006;6:621-9.
2. Lanier LL, Testi R, Bindl J, Phillips JH. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med. 1989;169:2233-8.
3. Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood. 2001;97:3146-51.
4. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol. 2001;22:633-40.
5. Caligiuri MA. Human natural killer cells. Blood. 2008;112:461-9.
6. Afonina IS, Cullen SP, Martin SJ. Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B. Immunol Rev. 2010;235:105-16.
7. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods. 2004;294:15-22.
8. O'Connor GM, Holmes A, Mulcahy F, Gardiner CM. Natural Killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function. Clin Immunol. 2007;124:277-83.
9. Alter G, Altfeld M. NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection. J Intern Med. 2009;265:29-42.
10. Biron CA, Turgiss LR, Welsh RM. Increase in NK cell number and turnover rate during acute viral infection. J Immunol. 1983;131:1539-45.
11. Alter G, Teigen N, Davis BT, Addo MM, Suscovich TJ, et al. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood. 2005;106:3366-9.
12. Titanji K, Sammicheli S, De Milito A, Mantegani P, Fortis C, et al. Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection. Immunology. 2008;123:164-70.
13. De Maria A, Moretta L. NK cell function in HIV-1 infection. Curr HIV Res. 2008;6:433-40.
14. Ahmad R, Sindhu ST, Tran P, Toma E, Morisset R, et al. Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients. J Med Virol. 2001;65:431-40.
15. Mavilio D, Benjamin J, Daucher M, Lombardo G, Kottilil S, et al. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc Natl Acad Sci U S A. 2003;100:15011-6.
16. Azzoni L, Papasavvas E, Chehimi J, Kostman JR, Mounzer K, et al. Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity. J Immunol. 2002;168:5764-70.
17. Ironson G, Balbin E, Solomon G, Fahey J, Klimas N, et al. Relative preservation of natural killer cell cytotoxicity and number in healthy AIDS patients with low CD4 cell counts. AIDS. 2001;15:2065-73.
18. Parato KG, Kumar A, Badley AD, Sanchez-Dardon JL, Chambers KA, et al. Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10. AIDS. 2002;16:1251-6.
19. Alter G, Malenfant JM, Delabre RM, Burgett NC, Yu XG, et al. Increased natural killer cell activity in viremic HIV-1 infection. J Immunol. 2004;173:5305-11.
20. Salgado M, Rallon NI, Rodes B, Lopez M, Soriano V, et al. Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors. Clin Immunol. 2011;139:110-4.
21. Van Duyne R, Guendel I, Kehn-Hall K, Easley R, Klase Z, et al. The identification of unique serum proteins of HIV-1 latently infected long-term non-progressor patients. AIDS Res Ther. 2010;7:21.
22. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006;107:4781-9.
23. Harrer T, Harrer E, Kalams SA, Elbeik T, Staprans SI, et al. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res Hum Retroviruses. 1996;12:585-92.
24. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science. 1997;278:1447-50.
25. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet. 2002;31:429-34.
26. Alter G, Teigen N, Ahern R, Streeck H, Meier A, et al. Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J Infect Dis. 2007;195:1452-60.
27. Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, et al. Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci U S A. 2005;102:2886-91.
28. Chang JJ, Altfeld M. Innate immune activation in primary HIV-1 infection. J Infect Dis. 2010;202 Suppl 2:S297-301.
29. Eller MA, Eller LA, Ouma BJ, Thelian D, Gonzalez VD, et al. Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection. J Acquir Immune Defic Syndr. 2009;51:380-9.
30. Kamya P, Tallon B, Melendez-Pena C, Parsons MS, Migueles SA, et al. Inhibitory killer immunoglobulin-like receptors to self HLA-B and HLA-C ligands contribute differentially to natural killer cell functional potential in HIV infected slow progressors. Clin Immunol. 2012;143:246-55.
31. Paroli M, Propato A, Accapezzato D, Francavilla V, Schiaffella E, et al. The immunology of HIV-infected long-term non-progressors-a current view. Immunol Lett. 2001;79:127-9.
32. Vieillard V, Fausther-Bovendo H, Samri A, Debre P. Specific phenotypic and functional features of natural killer cells from HIV-infected long-term nonprogressors and HIV controllers. J Acquir Immune Defic Syndr. 2010;53:564-73.
33. Zhang Z, Zhao QX, Fu JL, Yao JX, He Y, et al. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy. Chin Med J (Engl). 2006;119:1949-57.
34. Wu GQ, Zhao YM, Lai XY, Yang KL, Zhu FM, et al. Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations. Tissue Antigens. 2009;74:499-507.